QC
INFI

Quent Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Quent Capital’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-94
Closed -$15 – 1359
2023
Q1 		$15 Hold
94
– – ﹤0.01% 1316
2022
Q4 		$52 Sell
94
-298
-76% -$253 ﹤0.01% 1298
2022
Q3 		$0 Hold
392
– – ﹤0.01% 1300
2022
Q2 		$0 Hold
392
– – ﹤0.01% 1357
2022
Q1 		$0 Buy
+392
New +$468 ﹤0.01% 1340

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quent Capital's INFI Position: Q2 2023 in Review

Quent Capital sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2023, closing a stake of 94 shares — an estimated $15 sold.

Quent Capital first reported a position in INFI in Q1 2022 and held it in 5 quarters. The position peaked at $52 in Q4 2022. 45 funds tracked by Wall St. Rank hold INFI as of Q2 2023.

  • Quent Capital reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Quent Capital sold 94 Infinity Pharmaceuticals, Inc. shares in Q2 2023, an estimated $15.
  • Quent Capital first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2022 and held it in 5 quarters.
  • Quent Capital's Infinity Pharmaceuticals, Inc. position peaked at $52 in Q4 2022.
  • 45 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2023.

Based on Quent Capital's 13F filing for Q2 2023, filed 10 Jul 2023.